GAVI & Serum Institute of India
3 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
GAVI: GAVI, a global vaccine alliance, committed up to $50 million to the Ebola response, contributing to the overall funding for combating the outbreak.
Serum Institute of India: The Serum Institute of India is manufacturing a vaccine candidate developed by the University of Oxford, receiving up to $8.6 million from CEPI for its development.
May 22, 2026 · 36 articles
Accidents
GAVI: Making its RVSV-ZEBOV vaccine stockpile available for trials and supporting vaccine access. Its role is key in ensuring vaccine availability for the response.
Serum Institute of India: Manufactured a stockpile of 620,000 doses of the Oxford vaccine candidate. Its manufacturing capacity is crucial for potential large-scale deployment.
Mar 09, 2018 · 543 articles
Accidents
GAVI: GAVI>>> holds a stockpile of Ebola vaccines and has 2,000 doses already in the Democratic Republic of the Congo>>> for potential trial use.
Serum Institute of India: The Serum Institute of India is manufacturing doses of a vaccine candidate built on the University of Oxford/AstraZeneca platform, which could be used for clinical trials against the Bundibugyo ebolavirus.
May 18, 2026 · 505 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how GAVI and Serum Institute of India interact across events, view sentiment trends, and discover connected entities.
Open Dashboard